Observations on the launch of new drugs for hepatitis C
Aust Prescr
.
2018 Feb;41(1):4-5.
doi: 10.18773/austprescr.2018.005.
Epub 2018 Feb 1.
Authors
Marianne Martinello
1
,
Behzad Hajarizadeh
2
,
Gregory J Dore
3
Affiliations
1
Blacktown Mt Druitt Hospital, Blacktown, New South Wales.
2
Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Sydney.
3
St Vincent's Hospital, Sydney.
PMID:
29507451
PMCID:
PMC5828927
DOI:
10.18773/austprescr.2018.005
No abstract available
Keywords:
direct-acting antiviral drugs; hepatitis C.
Publication types
Editorial